Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06994520 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy of Topical Cannabidiol for Eczema

StatusEnrolling by Invitation
PhasePhase 2
Started2025-05-01
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 15 months later May 1, 2026 → Aug 1, 2027
See other at-risk trials from Khon Kaen University

Amendment history

2026-08-03
critical
Study Status v1
Trial status changed: Active, Not Recruiting → Enrolling by Invitation
Primary completion pushed: 2026-05-01 → 2027-08-01
Completion pushed: 2026-12-31 → 2027-12-31
2025-05-28
minor
Original filing
Itching is a common symptom encountered in general medical practice. It can cause significant discomfort, disrupt sleep, and impair patients' quality of life. Chronic pruritic skin conditions such as atopic dermatitis, nummular eczema, lichen simplex chronicus, and prurigo nodularis are frequently observed. The pathogenesis of these conditions remains incompletely understood, and effective long-term treatment options are limited. Current therapies include topical corticosteroids, topical calcineurin inhibitors, oral corticosteroids, and systemic immunosuppressants. However, these treatments are often associated with adverse effects, and the diseases tend to follow a chronic, relapsing course. Therefore, the investigators aim to investigate the efficacy and safety of topical cannabis extract in patients with chronic pruritic skin conditions.
Trial Details
NCT Number NCT06994520
Lead Sponsor Khon Kaen University
Conditions Chronic Pruritus, Eczema, Nummular Eczema, Atopic Dermatitis, Prurigo Nodularis
Enrollment 60 participants
Start Date 2025-05-01
Primary Completion 2027-08-01 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-04